John T. Treace, Chief Executive Officer at Treace Medical Concepts, bought TMCI on Jun 10, 2026
Data as of Oct 16
▲ BUY$118K29,430 shares at $4.02John T. Treace Chief Executive OfficerTMCI Treace Medical Concepts, Inc.
- Traded
- Jun 10, 2026
- Disclosed
- Jun 11, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
TMCI since disclosure
−1.0%
Similar stocks (XLV) since disclosure
+14.7%
XLV — its sector index fund
Change in closing price from Jun 11, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYJohn T. Treace Chief Executive OfficerTMCI Treace Medical Concepts, Inc.$92.5Kdisclosed Jun 11 · filed the same day